Trial intelligence / Profile preview

16448 in Premature Ejaculation

NCT00537459Phase 2Completed

Sponsor
GSK
Start
Dec 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of 16448 in premature ejaculation (PE), sponsored by GSK. Started Dec 2006; status: completed.

02

Drugs

16448
03

Conditions

premature ejaculation (PE)

Beyond the preview

Go deeper on NCT00537459.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00537459.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call